Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 52 Records) |
| Query Trace: Ovarian Neoplasms and BARD1[original query] |
|---|
| Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study. Journal of ovarian research 2019 Aug 12 (1): 80. Li Wenhui, Shao Di, Li Lei, Wu Ming, Ma Shuiqing, Tan Xianjie, Zhong Sen, Guo Fengming, Wang Zhe, Ye Mingz |
| Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 8 32 (Supplementum2): 6-13. Foretová Lenka, Navrátilová Marie, Svoboda Marek, Vaší?ková Petra, S?ahlová Eva Hrabincová, Házová Jana, Kleiblová Petra, Kleibl Zden?k, Machá?ková Eva, Palácová Markéta, Petráková Katarí |
| Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32 (Supplementum2): 72-78. Soukupová Jana, Lhotová Klára, Zemánková Petra, Vo?ka Michal, Janatová Markéta, Stola?ová Lenka, Borecká Marianna, Kleiblová Petra, Machá?ková Eva, Foretová Lenka, Koudová Monika, Lhota Filip, Tavandzis Spiros, Zikán Michal, Stránecký Viktor, Veselá Kamila, Panczak Aleš, Kotlas Jaroslav, Kleibl Zden |
| Age-adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls. Hereditary cancer in clinical practice 2019 7 17 19. Arvai Kevin J, Roberts Maegan E, Torene Rebecca I, Susswein Lisa R, Marshall Megan L, Zhang Zhancheng, Carter Natalie J, Yackowski Lauren, Rinella Erica S, Klein Rachel T, Hruska Kathleen S, Retterer Ky |
| Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer. Breast cancer research : BCR 2019 Apr 21 (1): 55. Weber-Lassalle Nana, Borde Julika, Weber-Lassalle Konstantin, Horváth Judit, Niederacher Dieter, Arnold Norbert, Kaulfuß Silke, Ernst Corinna, Paul Victoria G, Honisch Ellen, Klaschik Kristina, Volk Alexander E, Kubisch Christian, Rapp Steffen, Lichey Nadine, Altmüller Janine, Lepkes Louisa, Pohl-Rescigno Esther, Thiele Holger, Nürnberg Peter, Larsen Mirjam, Richters Lisa, Rhiem Kerstin, Wappenschmidt Barbara, Engel Christoph, Meindl Alfons, Schmutzler Rita K, Hahnen Eric, Hauke J |
| Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients. Clinical biochemistry 2019 Nov . Rodríguez-Balada Marta, Roig Bàrbara, Melé Mireia, Albacar Cinta, Serrano Sara, Salvat Mònica, Querol Montserrat, Borràs Joan, Martorell Lourdes, Gumà Jos |
| Exome Sequencing in BRCA1- and BRCA2-Negative Greek Families Identifies MDM1 and NBEAL1 as Candidate Risk Genes for Hereditary Breast Cancer. Frontiers in genetics 2019 10 1005. Glentis Stavros, Dimopoulos Alexandros C, Rouskas Konstantinos, Ntritsos George, Evangelou Evangelos, Narod Steven A, Mes-Masson Anne-Marie, Foulkes William D, Rivera Barbara, Tonin Patricia N, Ragoussis Jiannis, Dimas Antigone |
| Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer. Cancers 2020 8 12 (8): . Velázquez Carolina, K De Leeneer, Esteban-Cardeñosa Eva M, Avila Cobos Francisco, Lastra Enrique, Abella Luis E, de la Cruz Virginia, Lobatón Carmen D, Claes Kathleen B, Durán Mercedes, Infante M |
| Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers. Genes 2020 7 11 (8): . Alenezi Wejdan M, Fierheller Caitlin T, Recio Neil, Tonin Patricia |
| Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations. Genes 2020 7 11 (7): . Suszynska Malwina, Kozlowski Pio |
| Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome. NPJ breast cancer 2020 6 6 25. Kaneyasu Tomoko, Mori Seiichi, Yamauchi Hideko, Ohsumi Shozo, Ohno Shinji, Aoki Daisuke, Baba Shinichi, Kawano Junko, Miki Yoshio, Matsumoto Naomichi, Nagasaki Masao, Yoshida Reiko, Akashi-Tanaka Sadako, Iwase Takuji, Kitagawa Dai, Masuda Kenta, Hirasawa Akira, Arai Masami, Takei Junko, Ide Yoshimi, Gotoh Osamu, Yaguchi Noriko, Nishi Mitsuyo, Kaneko Keika, Matsuyama Yumi, Okawa Megumi, Suzuki Misato, Nezu Aya, Yokoyama Shiro, Amino Sayuri, Inuzuka Mayuko, Noda Tetsuo, Nakamura Sei |
| Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers 2020 4 12 (4): . Lhotova Klara, Stolarova Lenka, Zemankova Petra, Vocka Michal, Janatova Marketa, Borecka Marianna, Cerna Marta, Jelinkova Sandra, Kral Jan, Volkova Zuzana, Urbanova Marketa, Kleiblova Petra, Machackova Eva, Foretova Lenka, Hazova Jana, Vasickova Petra, Lhota Filip, Koudova Monika, Cerna Leona, Tavandzis Spiros, Indrakova Jana, Hruskova Lucie, Kosarova Marcela, Vrtel Radek, Stranecky Viktor, Kmoch Stanislav, Zikan Michal, Macurek Libor, Kleibl Zdenek, Soukupova Ja |
| The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort. Journal of the National Cancer Institute 2020 Feb . Hu Chunling, Polley Eric C, Yadav Siddhartha, Lilyquist Jenna, Shimelis Hermela, Na Jie, Hart Steven N, Goldgar David E, Shah Swati, Pesaran Tina, Dolinsky Jill S, LaDuca Holly, Couch Fergus |
| Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC medical genomics 2020 Feb 13 (1): 21. da Costa E Silva Carvalho Simone, Cury Nathalia Moreno, Brotto Danielle Barbosa, de Araujo Luiza Ferreira, Rosa Reginaldo Cruz Alves, Texeira Lorena Alves, Plaça Jessica Rodrigues, Marques Adriana Aparecida, Peronni Kamila Chagas, Ruy Patricia de Cássia, Molfetta Greice Andreotti, Moriguti Julio Cesar, Carraro Dirce Maria, Palmero Edenir Inêz, Ashton-Prolla Patricia, de Faria Ferraz Victor Evangelista, Silva Wilson Arau |
| Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition. Genes, chromosomes & cancer 2020 Oct . Cavaillé Mathias, Uhrhammer Nancy, Privat Maud, Ponelle-Chachuat Flora, Gay-Bellile Mathilde, Lepage Mathis, Molnar Ioana, Viala Sandrine, Bidet Yannick, Bignon Yves-Je |
| Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. International journal of cancer 2021 9 150 (2): 279-289. Quintanilha Julia C F, Wang Jin, Sibley Alexander B, Xu Wei, Espin-Garcia Osvaldo, Jiang Chen, Etheridge Amy S, Ratain Mark J, Lenz Heinz-Josef, Bertagnolli Monica, Kindler Hedy L, Dickler Maura N, Venook Alan, Liu Geoffrey, Owzar Kouros, Lin Danyu, Innocenti Federi |
| A synergetic effect of BARD1 mutations on tumorigenesis. Nature communications 2021 2 12 (1): 1243. Li Wenjing, Gu Xiaoyang, Liu Chunhong, Shi Yanyan, Wang Pan, Zhang Na, Wu Rui, Leng Liang, Xie Bingteng, Song Chen, Li |
| Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools. Cancer prevention research (Philadelphia, Pa.) 2021 12 15 (3): 151-160. Suszynska Malwina, Ratajska Magdalena, Galka-Marciniak Paulina, Ryszkowska Aleksandra, Wydra Dariusz, Debniak Jaroslaw, Jasiak Anna, Wasag Bartosz, Cybulski Cezary, Kozlowski Pio |
| RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant. Scientific reports 2021 11 11 (1): 22948. Rofes Paula, Pineda Marta, Feliubadaló Lídia, Menéndez Mireia, de Cid Rafael, Gómez Carolina, Montes Eva, Capellá Gabriel, Brunet Joan, Del Valle Jesús, Lázaro Con |
| Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing. Cancers 2021 10 13 (20): . Wessman Sandra, Fuentes Beatriz Bohorquez, Törngren Therese, Kvist Anders, Kokaraki Georgia, Menkens Hanna, Hjerpe Elisabet, Hugo Ythalo, Petta Tirzah Braz, Borg Åke, Carlson Joseph |
| Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer. Cancers 2021 Jan 13 (1): . Lepkes Louisa, Kayali Mohamad, Blümcke Britta, Weber Jonas, Suszynska Malwina, Schmidt Sandra, Borde Julika, Klonowska Katarzyna, Wappenschmidt Barbara, Hauke Jan, Kozlowski Piotr, Schmutzler Rita K, Hahnen Eric, Ernst Corin |
| BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort. Genes 2021 1 12 (2): . Rofes Paula, Del Valle Jesús, Torres-Esquius Sara, Feliubadaló Lídia, Stradella Agostina, Moreno-Cabrera José Marcos, López-Doriga Adriana, Munté Elisabet, De Cid Rafael, Campos Olga, Cuesta Raquel, Teulé Álex, Grau Èlia, Sanz Judit, Capellá Gabriel, Díez Orland, Brunet Joan, Balmaña Judith, Lázaro Con |
| Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants. Scientific reports 2022 May 12 (1): 8547. Benito-Sánchez B, Barroso A, Fernández V, Mercadillo F, Núñez-Torres R, Pita G, Pombo L, Morales-Chamorro R, Cano-Cano J M, Urioste M, González-Neira A, Osorio |
| Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. JCO precision oncology 2022 2 1 1-12. Kurian Allison W, Hughes Elisha, Handorf Elizabeth A, Gutin Alexander, Allen Brian, Hartman Anne-Renee, Hall Michael |
| Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. Journal of the National Cancer Institute 2022 10 115 (2): 181-189. Lim Belle W X, Li Na, Mahale Sakshi, McInerny Simone, Zethoven Magnus, Rowley Simone M, Huynh Joanne, Wang Theresa, Lee Jue Er Amanda, Friedman Mia, Devereux Lisa, Scott Rodney J, Sloan Erica K, James Paul A, Campbell Ian |
| Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. JCO precision oncology 2023 8 7 e2200695. Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Edward D Esplin, Anneke Lucassen, Nadine M Tung, Claudine Isaa |
| Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes. Scientific reports 2023 5 13 (1): 8536. Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Anne-Vibeke Lænkholm, Åke Borg, Anders Kvist, Therese Törngren, Uffe Birk Jensen, Susanne Eriksen Boonen, Mads Thomassen, Thorkild Terkels |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 525-530. Sukpan Panupong, Kanokwiroon Kanyanatt, Sriplung Hutcha, Laochareonsuk Wison, Choochuen Pongsakorn, Auseng Nasuha, Wanawanakorn Kasemsun, Sangkhathat Suras |
| Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers. Gynecologic oncology 2023 2 170 234-240. Lee Sarah S, Karpel Hannah C, Oh Cheongeun, Smith Julia, Pothuri Bhava |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: